Clinical Efficacy Observation and Safety Assessment of Acupotomy Therapy for Cervical Spondylosis-Related Neck Pain: A Randomized, Blinded, Parallel-Controlled Trial

INTERVENTION: Acupotomy group:acupotomy release therapy;Medication group:Oral celecoxib capsules; CONDITION: Cervical Spondylosis‐Related Neck Pain PRIMARY OUTCOME: Neck Pain Visual Analogue Scale Score; SECONDARY OUTCOME: Neck Disability Index;Range of Motion measurement;Short Form‐36 Short Form Health Survey; INCLUSION CRITERIA: (1)Meets the diagnostic criteria for cervical spondylosis‐related neck pain: The patient reports abnormal sensations such as pain in the occipital region, neck, and shoulders, which may be accompanied by corresponding tender points; imaging findings reveal degenerative changes in the cervical spine; other cervical disorders or diseases causing neck symptoms are excluded. (2) Age 18‐70 years, gender unrestricted. (3) Cervical spondylosis‐related neck pain with VAS score =4 (on a 0‐10 scale), symptoms persisting =2 weeks but <3 months. (4) No administration of nonsteroidal anti‐inflammatory drugs (NSAIDs) or muscle relaxants within the past week, and no cervical traction, massage, acupuncture, or minimally invasive treatments received within the past month. (5) Voluntarily sign the informed consent form and cooperate with the completion of treatment and 3‐month follow‐up. Only patients meeting all five criteria above were eligible for inclusion in this